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We are only beginning to understand the relationship
between host genetics and the gut microbiome. Two
recent studies help to disentangle this interaction and
show that genetic loci across the human genome shape
the gut microbiome. This opens the possibility that
an unexpected number of genetic factors act directly
on microbial composition and function to modulate
immune pathways and metabolic phenotypes in host
physiology and disease.power due to a limited number of twin pairs (54 orAssociation of host genetics and the microbiome
The small intestine and colon house a complex bacterial
ecosystem that plays a critical role in host metabolism
and immunity. Variation in the microbiome within human
populations may influence susceptibility to diseases such as
obesity and inflammatory bowel disease (IBD), motivating
efforts to understand the determinants of the composition
of the intestinal microbiome. There is extensive literature
on the effects of diet, antibiotic exposure, colonization
history and other environmental factors. Whether host
genetics also influences the microbiome is of growing
interest; two recent studies, one by Goodrich et al. in Cell
[1] and the other by Knights et al. in Genome Medicine
[2], have addressed this question.
It was already known that microbial composition is
altered when genes that encode host mechanisms for
microbial sensing and effector functions were knocked
out in mouse models [3]. Other studies had also shown
that genetic disruption of host microbial regulation in
animals can induce susceptibility to colitis or metabolic
syndrome. This susceptibility is transmissible via the
microbiome, demonstrating the relevance of gene-microbe
interactions to human health [4,5].* Correspondence: jbraun@mednet.ucla.edu
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unless otherwise stated.In humans, it is unclear whether genetic variation in
human populations contributes to the inter-individual
diversity in the human intestinal microbiome. This question
can been addressed by evaluating whether the composition
of the microbiome is more similar between monozygotic
twin pairs than between dizygotic twin pairs, an approach
that controls for shared environmental factors. Two early
studies using high-throughput 16S sequencing reported no
difference in microbial similarity between monozygotic
twins compared with dizygotic twins using a phylogenetic
similarity measure [6,7]. However, these studies had low
fewer) and global endpoints of microbial composition
(for example, principal component analysis), leaving the
issue open to debate.
In this issue of Genome Medicine, Knights et al.
present a systematic analysis of the effect of 154 IBD-
associated polymorphisms on microbial composition in
three cohorts of patients with IBD (152 to 162 patients
in each cohort) [2]. The authors created multivariate
linear models incorporating the IBD-associated polymor-
phisms and various clinical metadata to predict the
abundance of bacterial taxa present in at least 75% of
samples. Genetic variants associated with altered taxa
abundance in one cohort were then cross-compared to
the other two cohorts to determine if the directionality
of change was conserved across cohorts. A total of 49
IBD-associated genes, representing nearly a third of the
known IBD-associated genes, affected microbial taxa in
a concordant manner in at least two of the cohorts.
Three Reactome pathways were enriched in these genes:
innate immune response, inflammatory response and the
JAK-STAT cascade. These findings are consistent with
animal studies demonstrating that perturbation in immune
function can greatly influence microbial composition.
The six known disease-associated variants of NOD2, an
intracellular sensor of bacterial products, were combined
in a separate analysis. They were found to influence
overall microbial composition and the abundance ofntral Ltd. The licensee has exclusive rights to distribute this article, in any
ion. After this time, the article is available under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Jacobs and Braun Genome Medicine 2014, 6:119 Page 2 of 3
http://genomemedicine.com/content/6/12/119Enterobacteriaceae. Although NOD2 was one of the
strongest microbiome-associated genetic variants, in
linear models it had a modest effect relative to clinical
metadata, such as antibiotic usage. This suggests that
the influence of genetics is likely to be highly specific
and requires careful study design to separate it from
the many environmental influences on the microbiome.
A heritable taxon protective against obesity
These concepts are echoed in a structurally distinct
study by Goodrich et al. in the November issue of Cell,
which analyzed a host genomic input on fecal microbial
composition, utilizing the power of twin studies (TwinsUK
cohort;171 monozygotic twin pairs and 245 dizygotic twin
pairs) [1]. The increased statistical power compared with
earlier twin studies allowed the authors to identify a
statistically significant increased similarity in microbial
composition within monozygotic twin pairs compared with
dizygotic twin pairs. Moreover, the effect of genetics was
found to be stronger for some bacterial families than others.
Among the three dominant families, Lachnospiraceae and
Ruminococcaceae composition were significantly more
similar within monozygotic twin pairs whereas Bacteroi-
daceae composition did not differ between twin types.
The most highly heritable family was Christensenellaceae,
which correlated strongly with several other taxa, including
Methanobacteriaceae, which were also highly heritable.
This network was enriched in lean individuals compared
with obese individuals, suggesting the existence of a herit-
able consortium of bacteria that protect against obesity.
Human microbial reconstitution studies using germ-free
mice confirmed the predicted association of Christense-
nellaceae colonization with the lean phenotype.
Genotype-microbiome interaction to disease
phenotype: a complex interplay
The findings of Goodrich et al. suggest that heritable
susceptibility to diseases such as obesity may be partially
attributable to genetic factors that change the micro-
biome, although the specific common genetic variants in
the human population that influence the microbiome
remain unknown. Knights et al. successfully tackled this
issue by identifying 49 IBD-associated polymorphisms
that were correlated with microbial composition in some
of their IBD cohorts. Indeed, many of the 163 known
IBD genetic risk loci are involved in host-microbe inter-
actions [8].
Existing studies of candidate IBD-associated genetic
variants have identified alterations in the intestinal micro-
biome in individuals carrying polymorphisms in NOD2
and FUT2, an enzyme that fucosylates mucus glycopro-
teins [9,10]. The challenge now is to clarify if these
variants contribute to disease phenotype through their
direct influence on microbiome selection, whose productsin turn elicit the disease phenotype. This question can
be addressed by determining if genetic polymorphisms
concordantly affect microbial composition in healthy
individuals. Considerable further work will be required
to elucidate the mechanisms underlying the observed
genetic associations with microbial composition in these
two studies. This will entail large-scale genome-wide asso-
ciation studies in both healthy individuals and individuals
with microbiome-associated disease, similar to the study
by Knights et al., paired with validation using gene-
targeted and human gnotobiotic mice. Such investigations
will not only aid our understanding of human disease,
but could unmask microbes such as Christensenella
minuta that are relevant to human health and could be
manipulated for therapeutic purposes.
Abbreviation
IBD: Inflammatory bowel disease.
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